Back to Search Start Over

Generation of a laminopathies-specific iPSC line EHTJUi005-A-3 with homozygous knockout of the LMNA gene by CRISPR/Cas9 technology.

Authors :
Lu JZ
Qiao ZB
Zhang L
Cao HX
Bai ZH
Qi YY
Zhu HY
Chen YQ
Zhang SM
Yan XH
Bao Y
Jia WW
Liu ZM
Source :
Stem cell research [Stem Cell Res] 2021 Oct; Vol. 56, pp. 102530. Date of Electronic Publication: 2021 Sep 03.
Publication Year :
2021

Abstract

LAMIN A/C, encoded by the LMNA gene, supports the normal structure of the cell nucleus and regulates the connection between the nucleus and the cytoskeleton as a component of the nucleus envelope. The loss of expression and function of the LMNA gene would lead to the occurrence of congenital muscular dystrophy and Emery-Dreifuss muscular dystrophy which are collectively named as laminopathies. Here, we report a human induced pluripotent stem cell (iPSC) line (EHTJUi005-A-3) generated from a wild iPSC (EHTJUi005-A) with homozygous knockout of the gene LMNA through CRISPR/Cas9. This iPSC line provides a useful research model for studying laminopathies disease.<br /> (Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1876-7753
Volume :
56
Database :
MEDLINE
Journal :
Stem cell research
Publication Type :
Academic Journal
Accession number :
34507144
Full Text :
https://doi.org/10.1016/j.scr.2021.102530